Novo Nordisk A/S (NVO)

Last Closing Price: 62.62 (2025-04-28)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Novo Nordisk A/S (NVO) had Revenue of $12.26B for the most recently reported fiscal quarter, ending 2024-12-31.

Figures for fiscal quarter ending 2024-12-31
Income Statement Financials
Revenue
$12.26B
$4.03B
$1.86B
$10.40B
$7.02B
$5.24B
$-172.91M
$5.07B
$5.07B
$4.03B
$4.03B
$4.03B
$4.03B
$5.24B
$5.97B
4.45B
4.46B
$0.90
$0.90
Balance Sheet Financials
$23.33B
$23.56B
$44.21B
$67.54B
$31.54B
$13.00B
$15.19B
$46.73B
$20.81B
$4.70B
$20.81B
4.46B
Cash Flow Statement Financials
$17.54B
$-18.69B
$1.27B
$2.09B
$2.27B
$183.13M
$331.90M
$-6.40B
--
Fundamental Metrics & Ratios
0.74
--
--
0.38
0.72
84.81%
42.77%
42.77%
--
41.36%
32.84%
$10.70B
--
--
--
0.18
0.31
0.97
93.04
19.35%
85.72%
5.96%
11.91%
$4.66
$2.40
$3.93